112 related articles for article (PubMed ID: 1715775)
1. Immortalization of magnetically separated human lymphocytes by electrofusion.
Glaser RW; Volk HD; Liebenthal C; Jahn S; Grunow R
Hum Antibodies Hybridomas; 1990; 1(2):111-4. PubMed ID: 1715775
[TBL] [Abstract][Full Text] [Related]
2. Efficient immortalization of rheumatoid synovial tissue B-lymphocytes. A comparison between the techniques of electric field-induced and PEG fusion.
Krenn V; von Landenberg P; Wozniak E; Kissler C; Hermelink HK; Zimmermann U; Vollmers HP
Hum Antibodies Hybridomas; 1995; 6(2):47-51. PubMed ID: 7492750
[TBL] [Abstract][Full Text] [Related]
3. Efficient electric field-induced generation of hybridomas from human B lymphocytes without prior activation in vitro.
Kwekkeboom J; de Groot C; Tager JM
Hum Antibodies Hybridomas; 1992 Jan; 3(1):48-53. PubMed ID: 1576322
[TBL] [Abstract][Full Text] [Related]
4. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
[TBL] [Abstract][Full Text] [Related]
5. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
Glaser RW; Jahn S; Grunow R
Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
[TBL] [Abstract][Full Text] [Related]
6. Rapid separation of CD4+ and CD19+ lymphocyte populations from human peripheral blood by a magnetic activated cell sorter (MACS).
Semple JW; Allen D; Chang W; Castaldi P; Freedman J
Cytometry; 1993 Nov; 14(8):955-60. PubMed ID: 7507026
[TBL] [Abstract][Full Text] [Related]
7. Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation.
Funderud S; Erikstein B; Asheim HC; Nustad K; Stokke T; Blomhoff HK; Holte H; Smeland EB
Eur J Immunol; 1990 Jan; 20(1):201-6. PubMed ID: 1689662
[TBL] [Abstract][Full Text] [Related]
8. Human-human B cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency.
Denis KA; Wall R; Saxon A
J Immunol; 1983 Nov; 131(5):2273-8. PubMed ID: 6313803
[TBL] [Abstract][Full Text] [Related]
9. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.
Rickert RC; Rajewsky K; Roes J
Nature; 1995 Jul; 376(6538):352-5. PubMed ID: 7543183
[TBL] [Abstract][Full Text] [Related]
10. In vitro stimulation of human peripheral blood B cells from normal individuals by activated T cells increases the efficiency of hybridoma generation.
Ferraro AS; Newkirk MM
Hum Antibodies Hybridomas; 1993 Apr; 4(2):80-5. PubMed ID: 8100151
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three human-murine heteromyeloma cell lines for formation of human hybridomas after electrofusion with human peripheral blood lymphocytes from meningococcal cases and carriers.
Delvig AA; Koumaré B; Glaser RW; Wang JF; Jahn S; Achtman M
Hum Antibodies Hybridomas; 1995; 6(2):42-6. PubMed ID: 7492749
[TBL] [Abstract][Full Text] [Related]
12. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
13. Single, antigen-specific B cells used to generate Fab fragments using CD40-mediated amplification or direct PCR cloning.
Lagerkvist AC; Furebring C; Borrebaeck CA
Biotechniques; 1995 May; 18(5):862-9. PubMed ID: 7542459
[TBL] [Abstract][Full Text] [Related]
14. The CD40 ligand expressed by human B cells costimulates B cell responses.
Grammer AC; Bergman MC; Miura Y; Fujita K; Davis LS; Lipsky PE
J Immunol; 1995 May; 154(10):4996-5010. PubMed ID: 7537298
[TBL] [Abstract][Full Text] [Related]
15. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
Perkins S; Foung SK
Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
[No Abstract] [Full Text] [Related]
16. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies.
Bohlen H; Manzke O; Patel B; Moldenhauer G; Dörken B; von Fliedner V; Diehl V; Tesch H
Cancer Res; 1993 Sep; 53(18):4310-4. PubMed ID: 7689932
[TBL] [Abstract][Full Text] [Related]
17. Secretion of human monoclonal antibody after fusion of an immortal T cell line and lymphocytes from the peripheral blood of a patient with colon carcinoma.
Dillman SL; Aldenderfer P; Strelkauskas A
Hum Antibodies Hybridomas; 1994; 5(1-2):32-40. PubMed ID: 7858181
[TBL] [Abstract][Full Text] [Related]
18. Establishment of antigen-specific and MHC-restricted B cell hybridoma clones: a model for studying antigen presentation to T cell lines and clones.
Zimecki M; Kapp JA; Pierce CW
Arch Immunol Ther Exp (Warsz); 1988; 36(4):395-408. PubMed ID: 2471476
[TBL] [Abstract][Full Text] [Related]
19. Antigen presentation to T cell lines and clones by peritoneal macrophages, peritoneal B cells and antigen-specific B cell hybridomas.
Zimecki M; Abruzzini AF; Pierce CW; Kapp JA
Arch Immunol Ther Exp (Warsz); 1988; 36(4):409-22. PubMed ID: 2471477
[TBL] [Abstract][Full Text] [Related]
20. Production of T-T hybrids from T cell clones. Direct comparison between cloned T cells and T hybridoma cells derived from them.
Ozaki S; Durum SK; Muegge K; York-Jolley J; Berzofsky JA
J Immunol; 1988 Jul; 141(1):71-8. PubMed ID: 2454265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
